Complete Price Breakdown: Mounjaro vs Wegovy Comparison
Mounjaro vs Wegovy Weight Loss: Why Hidden Fees Matter
When comparing Mounjaro vs Wegovy weight loss options, many UK patients discover unexpected charges at checkout from other providers. Consultation fees ranging from £30-60, prescription charges, and delivery costs can double your actual spend. EverydayMeds eliminates this frustration through radical price transparency.
Our Mounjaro vs Wegovy weight loss pricing includes every element of your treatment journey. Whether you choose Wegovy's GLP-1 receptor approach or Mounjaro's dual GIP+GLP-1 mechanism, you'll see the complete cost upfront. This transparency extends beyond pricing to clinical support, with our GPhC #9012878 registered pharmacists available throughout your weight management programme.
Transparent Wegovy Pricing Structure
Our Wegovy pricing demonstrates true cost transparency: 0.25mg starter dose £79.99, 0.5mg £94.99, 1mg £99.99, 1.7mg £139.99, and 2.4mg maintenance £209.99. These prices include clinical assessment, prescriber review, prescription, and next-day cold-chain delivery. New customers apply code FIRST40, returning patients use DOSE25 at checkout.
Bundle options provide supply security without hidden markups. Our Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Ultimate Stability Trio (three 2.4mg maintenance pens) provides £649.99 for quarterly supply. Compare this to competitors charging separate consultation fees that can add £180+ annually to your Mounjaro vs Wegovy weight loss investment.
Clinical Evidence for Mounjaro vs Wegovy Weight Loss
The STEP trials demonstrated Wegovy's effectiveness, with patients achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle modifications (Wilding et al., NEJM, 2021). Mounjaro's SURMOUNT trials showed similar impressive results with its dual hormone approach. Both treatments represent significant advances in prescription weight management.
However, these Mounjaro vs Wegovy weight loss studies used different trial designs and patient populations, making direct percentage comparisons inappropriate. Your prescriber can help determine which mechanism - Wegovy's GLP-1 focus or Mounjaro's dual approach - aligns best with your individual health profile and weight management goals.
How Wegovy Supports Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. This prescription-only medicine works by reducing appetite signals in your brain's appetite centres while promoting satiety after smaller meals. Many patients report decreased food cravings and improved portion control. The once-weekly FlexTouch pen delivers consistent medication levels, supporting sustainable weight management alongside your reduced-calorie diet and increased physical activity. Clinical studies suggest this mechanism can help patients achieve meaningful weight loss when combined with lifestyle modifications.
Streamlined Ordering Process
Our transparent Mounjaro vs Wegovy weight loss service begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Following submission, our prescribers conduct thorough reviews within 3 working days (24-hour express option available). Once approved, your medication ships via next-day cold-chain delivery to maintain optimal temperature throughout transit. This comprehensive service operates under our GPhC #9012878 registration, ensuring full regulatory compliance. You'll receive tracking information and storage guidance with every delivery, plus ongoing clinical support throughout your treatment.
Storage and Practical Considerations
Wegovy offers practical advantages in the Mounjaro vs Wegovy weight loss comparison through superior storage flexibility. Once removed from refrigeration, Wegovy remains stable for 6 weeks at room temperature below 30°C, compared to Mounjaro's 21-day limit. Store unused pens at 2-8°C until needed, making travel and lifestyle management easier. The FlexTouch pen system provides accurate dosing through mandatory escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), progressing to 2.4mg maintenance. This graduated approach helps minimise side effects while optimising effectiveness for long-term weight management success.
Why Pricing Transparency Matters for Weight Loss Medication
Weight management represents a long-term health investment, making cost predictability essential for treatment adherence. Many patients abandon Mounjaro vs Wegovy weight loss programmes due to unexpected fees accumulating over months. Research indicates that financial surprises contribute significantly to medication discontinuation rates.
Our transparent model eliminates these barriers by providing clear monthly costs from treatment initiation. Whether choosing Wegovy's proven GLP-1 approach or considering Mounjaro's dual mechanism, you'll understand your total investment upfront. This clarity supports informed decision-making and long-term treatment commitment essential for sustainable weight management success.
Start Your Transparent Weight Loss Journey
Both Mounjaro and Wegovy are available through EverydayMeds with identical transparent pricing principles. New customers save with code FIRST40, whilst returning patients use DOSE25 for continued transparent pricing. Our clinical assessment takes just minutes, with prescriber review and next-day delivery completing your seamless experience. Visit https://everydaymeds.co.uk/collections/wegovy to begin your transparent weight management journey today. Remember, both treatments require ongoing commitment alongside dietary changes and exercise for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
